New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 7, 2014
07:30 EDTILMNIllumina weakness creates buying opportunity, says Wells Fargo
Wells Fargo believes that the recent decline in Illumina's stock is mostly related to its correlation with biotech indices, and the firm sees this correlation as "a technical rather than a fundamental phenomenon." The firm believes that demand for the company's HiSeq, MiSeq, and HiSeq X instruments are strong, and it now identifies the stock as its top pick in the tools space. It increased its price target on the shares to $170-175 from $155-$160.
News For ILMN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2016
06:23 EDTILMNIllumina downgraded to Hold from Buy at Canaccord
Subscribe for More Information
February 3, 2016
10:02 EDTILMNIllumina falls sharply after results
The company's report last night after the close disappointed investors, with shares currently down over 6.5% to $144.30. At that price next support is at $139.16. Resistance is at $146.56.
09:19 EDTILMNOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Boot Barn (BOOT), up 20.7%... Oclaro (OCLR), up 8.2%... Edwards Lifesciences (EW), up 5.8%... Natural Health (NHTC), up 5.7%... Viavi Solutions (VIAV), up 2.8%. ALSO HIGHER: Conatus (CNAT), up 18.8% after the FDA has granted Fast Track designation to the company's emricasan development program for the treatment of liver cirrhosis... Marvell Technology (MRVL), up 3.3% after Starboard Value disclosed a 6.7% activist stake in the company... Syngenta (SYT), up 2.9% after ChemChina offers to acquire the company in a transaction valued over $43B. DOWN AFTER EARNINGS: Navios Maritime Partners (NMM), down 33.5%... National-Oilwell Varco (NOV), down 7.9%... Chipotle (CMG), down 5.7%... Yahoo (YHOO), down 1.9%... Mondelez (MDLZ), down 4.4%... Illumina (ILMN), down 4.6%... Alexion Pharmaceuticals (ALXN), down 3.5%... Merck (MRK), down fractionally.
February 2, 2016
16:34 EDTILMNIllumina sees FY16 EPS $3.55-$3.65, consensus $3.64
Subscribe for More Information
16:34 EDTILMNIllumina reports Q4 EPS 81c, consensus 82c
Reports Q4 revenue $591.5M, consensus $585.18M.
14:32 EDTILMNNotable companies reporting after market close
Subscribe for More Information
13:11 EDTILMNIllumina technical comments ahead of earnings
Subscribe for More Information
February 1, 2016
15:21 EDTILMNIllumina volatility elevated into Q4 and outlook
Illumina February weekly call option implied volatility is at 84, February is at 54, March is at 45; compared to its 52-week range of 22 to 64, suggesting large near term price movement into the expected release of Q4 results on February 2.
06:33 EDTILMNIllumina signs four biobanking deals
Subscribe for More Information
January 28, 2016
11:18 EDTILMNOptions with increasing put volume
Options with increasing put volume: DRII SNE LH CAVM KSS UCO ILMN JBLU AVT SWK JNPR RRC CL HES
10:05 EDTILMNHigh option volume stocks
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use